InterVenn Biosciences makes Malaysia its regional hub
US-based clinical technology company, InterVenn® Biosciences made Malaysia its regional hub for delivery of its medical healthcare services and products across Asean and Asia-Pacific regions.
InterVenn co-founder and CEO Aldo Carrascoso (right) said the main decision in choosing Malaysia as a regional hub is because he wanted to be close by with the experts and patients in the region who were besieged by the disease — in line with his mission that no one should ever be blindsided by the disease.
“Here at InterVenn, maladies are holistically understood, adequately controlled and even manipulated to benefit all. We exist today to revisit the health-disease spectrum with an unprecedented and exclusive focus on “glyco” while incorporating the latest technological advancements and fully supporting our Malaysian office with those tools,” he said in a statement today.
Meanwhile, InterVenn Malaysia’s GM Fadzhairi Jabar said a part of this growth was a result of the support of regional collaborators and partners, as well as recognition given by the relevant government agency and research institutions. Read More...